|
|
Vexol (Rimexolone 1%) Ophthalmic Suspension
|
 |
Ophthalmic/Otic agent
|
 |
Corticosteroid
|
 |
Treatment of inflammation following eye surgery, Anterior uveitis
|
 |
Adults: for treatment of postoperative eye inflammation: usually, 1-2 drops into affected eye(s) 4 times a day. Uveitis: 1-2 drops into the affected eyes every hour while awake for the first week, then 1 drop every 2 hours during waking hours for the second week, then taper until resolved.
|
 |
Category C
|
 |
Increased eye pressure, Blurred Vision, burning, stinging, redness of eyes, foreign body sensation, itching, nausea, vomiting, photosensitivity, discharge from the eyes
|
Pregnancy Risk Categories defined:
A: Studies in pregnant women failed to show a risk to the fetus in the first
trimester - with no evidence of risk in the later trimesters.
B: Animals studies indicate no adverse effect to the fetus, but there are no adequate,
clinical studies in pregnant women.
C: Animal studies have shown an adverse effect on the fetus, but there are no adequate,
clinical studies in humans. Despite potential risks, the drug may be useful in pregnant
women.
D: There is evidence of risk to the human fetus, but the potential benefits of use in
pregnant women may be acceptable, despite potential risks.
X: Studies in animals or humans show fetal abnormalities, or adverse reaction reports
indicate evidence of fetal risk. Warning: the risks involved clearly outweigh any
potential benefit from using the drug in pregnant women, regardless of trimester.
NR: Not rated (i.e., no information available at this time as to the potential
risks or benefits).
|
| | |
If you want your friend to read or know about this article, Click here
 |
|
|
